£1.2M
The funding combines angel investment with Innovate UK support to advance medical technology development.
Developing technologies to improve patient safety and mitigate blood clot risks.
Leeds-based medical technology company developing solutions to improve patient safety and reduce risks associated with blood clots.
Cash at bank
Net current assets
Net assets
Shareholders' funds
Current assets
Employees
Cash, assets and headcount from ClotProtect's latest Companies House filing — with year-on-year movement, free with a Winfred account.

The funding combines angel investment with Innovate UK support to advance medical technology development.